@msmrstx So I'm speculating on medium-term price gains. If you are taken over, that's fine too. There are good partnerships with big players (e.g. Pfizer, Bristol Meyers) and since it's a relatively small position now, I think the opportunity costs will be rather low, I'll let it run for now :)